{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:20:40Z","timestamp":1773958840618,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.neuropharm.2007.12.013","type":"journal-article","created":{"date-parts":[[2008,1,20]],"date-time":"2008-01-20T00:51:08Z","timestamp":1200790268000},"page":"824-836","source":"Crossref","is-referenced-by-count":26,"title":["Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats"],"prefix":"10.1016","volume":"54","author":[{"given":"S.","family":"Stoji\u010di\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Milutinovi\u0107-Smiljani\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"\u0160arenac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Milosavljevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.R.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Japund\u017ei\u0107-\u017digon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.12.013_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1113\/jphysiol.2006.115766","article-title":"A\u00a0spinal vasopressinergic mechanism mediates hyperosmolality-induced sympathoexcitation","volume":"576","author":"Antunes","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","article-title":"Guidelines for the rational use of benzodiazepines. When and what to use","volume":"4","author":"Ashton","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/13543784.14.5.601","article-title":"The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics","volume":"14","author":"Atack","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.HYP.0000115384.01463.61","article-title":"Steady-state and dynamic responses of renal sympathetic nerve activity to air-jet stress in sinoaortic denervated rats","volume":"43","author":"Barr\u00e8s","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/01.HYP.16.3.213","article-title":"Central role for vasopressin in cardiovascular regulation and the pathogenesis of hypertension","volume":"16","author":"Berecek","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pneurobio.2003.11.001","article-title":"Functional organization of central cardiovascular pathways: studies using c-fos gene expression","volume":"71","author":"Dampney","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10253890500456287","article-title":"Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction","volume":"8","author":"Dobruch","year":"2005","journal-title":"Stress"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0306-4530(96)00006-6","article-title":"Endocrine and behavioural effects of air puff-startle in rats","volume":"21","author":"Engelmann","year":"1996","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib10","doi-asserted-by":"crossref","first-page":"H2891","DOI":"10.1152\/ajpheart.2001.280.6.H2891","article-title":"Descending pathways mediating cardiovascular response from dorsomedial hypothalamic nucleus","volume":"280","author":"Fontes","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib11","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","article-title":"Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders","volume":"99","author":"Griebel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/01.HYP.17.6.755","article-title":"Role of anteroventral third ventricle and vasopressin in renal response to stress in borderline hypertensive rats","volume":"17","author":"Hatton","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib13","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/en.133.4.1708","article-title":"Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin","volume":"133","author":"Hauger","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib14","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/en.142.4.1659","article-title":"Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin","volume":"142","author":"Hernando","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0922-4106(94)90226-7","article-title":"Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats","volume":"267","author":"Hirasawa","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0361-9230(86)90038-9","article-title":"The projections of the dorsomedial hypothalamic nucleus in the rat","volume":"16","author":"ter Horst","year":"1986","journal-title":"Brain Res. Bull."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2007.12.013_bib17","doi-asserted-by":"crossref","first-page":"11s","DOI":"10.1111\/j.1472-8206.1998.tb01026.x","article-title":"Hemodynamic basis of blood pressure variability in normotensive and spontaneously hypertensive rats","volume":"12","author":"Janssen","year":"1998","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-1838(90)90132-3","article-title":"Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers","volume":"30","author":"Japund\u017ei\u0107","year":"1990","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/10641969809053219","article-title":"Physiological mechanisms in regulation of blood pressure fast frequency variations","volume":"20","author":"Japund\u017ei\u0107-\u017digon","year":"1998","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib20","unstructured":"Japund\u017ei\u0107-\u017digon, N., Stoji\u010di\u0107, S., Milutinovi\u0107, S., \u0160arenac, O., Milosavljevi\u0107, S., Paton, J.F.R., Murphy, D., 2006. Central vasopressin mechanisms contribute to the mediation of the cardiovascular response to stress. Focused Meeting of the Physiological Society. New Developments in Stress Physiology \u2013 From Gene to Man, 4\u20135th December, University of Bristol, UK. Abstracts 2P."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152706776359664","article-title":"The involvement of the vasopressin system in stress-related disorders","volume":"5","author":"Landgraf","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib22","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.15-06-04250.1995","article-title":"V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behaviour in rats","volume":"15","author":"Landgraf","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.HYP.0000047875.43777.79","article-title":"Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension","volume":"41","author":"Li","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1113\/expphysiol.2006.036830","article-title":"Brain superoxide as a key regulator of the cardiovascular response to emotional stress in rabbits","volume":"92","author":"Mayorov","year":"2007","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib25","doi-asserted-by":"crossref","first-page":"R1579","DOI":"10.1152\/ajpregu.00764.2005","article-title":"The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study","volume":"291","author":"Milutinovi\u0107","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib26","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/01.CIR.92.7.1720","article-title":"Triggering of acute myocardial infarction onset by episodes of anger","volume":"92","author":"Mittleman","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autneu.2005.09.005","article-title":"Central autonomic integration of psychological stressors: focus on cardiovascular modulation","volume":"123","author":"McDougall","year":"2005","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib28","doi-asserted-by":"crossref","first-page":"R1276","DOI":"10.1152\/ajpregu.2001.280.5.R1276","article-title":"Injection of muscimol in dorsomedial hypothalamus and stress-induced Fos expression in paraventricular nucleus","volume":"280","author":"Morin","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-2999(02)02652-3","article-title":"Vasopressin V(1) receptor-mediated activation of central sympatho-adrenomedullary outflow in rats","volume":"457","author":"Okada","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2170\/jjphysiol.36.1253","article-title":"Potentiation of vasopressin secretion by footshock in rats","volume":"36","author":"Onaka","year":"1986","journal-title":"Jpn. J. Physiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/en.131.1.533","article-title":"Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain","volume":"131","author":"Ostrowski","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/en.135.4.1511","article-title":"Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature","volume":"135","author":"Ostrowski","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib33","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.HYP.25.6.1276","article-title":"Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal","volume":"25","author":"Parati","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000097587","article-title":"Supression of adernocortocotrophic hormone secretion by simultaneous antagonism of vasopressin 1b and CRH-1 receptors on three different stress models","volume":"84","author":"Ramos","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib35","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.CIR.99.16.2192","article-title":"Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy","volume":"99","author":"Rozanski","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jacc.2004.12.005","article-title":"The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging fields of behavioural cardiology","volume":"45","author":"Rozanski","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuroscience.2005.12.041","article-title":"Excitatory amino acid receptors in the periaqueductal grey mediate the cardiovascular response evoked by activation of dorsomedial hypothalamic neurons","volume":"139","author":"da Silva","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib38","first-page":"53","article-title":"An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders","volume":"11","author":"Serradeil-Le Gal","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.npp.1300562","article-title":"Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415","volume":"30","author":"Stemmelin","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1515\/BMT.2006.053","article-title":"Central vasopressin V(1a) and V(1b) receptors modulate the cardiovascular response to air-jet stress in conscious rats","volume":"51","author":"Stoji\u010di\u0107","year":"2006","journal-title":"Biomed. Tech."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.41.1.175","article-title":"The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists","volume":"41","author":"Thibonnier","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00230299","article-title":"The inhibitory effect of the ventrolateral periaqueductal grey matter on neurons in the rostral ventrolateral medulla involves a relay in the medullary raphe nuclei","volume":"94","author":"Wang","year":"1993","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib44","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0306-4522(97)00683-0","article-title":"Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons","volume":"85","author":"Wotjak","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.12.013_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neures.2006.09.011","article-title":"Periaqueductal gray knockdown of V2, not V1a and V1b receptor influences nociception in the rat","volume":"57","author":"Yang","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2007.12.013_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuropharm.2006.08.024","article-title":"Benzodiazepine inhibits hypothalamic presympathetic neurons by potentiation of GABAergic synaptic input","volume":"52","author":"Zahner","year":"2007","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T02:30:33Z","timestamp":1557196233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0028390808000038"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.12.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}